Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of suffering from various malignancies. This study aimed to identify specific biomarkers that can detect lung adenocarcinoma (LAC) in T2DM patients for the early diagnosis of LAC. METHODS: The clinical information of ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiayue, Yang, Cheng, Shen, Hong, Wu, Wenjun, Tian, Zhen, Xu, Qinghua, Cao, Cuiping, Ye, Shugao, Ban, Le, Tong, Xin, Mei, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945354/
https://www.ncbi.nlm.nih.gov/pubmed/33691685
http://dx.doi.org/10.1186/s12935-021-01861-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945354/
https://www.ncbi.nlm.nih.gov/pubmed/33691685
http://dx.doi.org/10.1186/s12935-021-01861-8

Ejemplares similares